221 related articles for article (PubMed ID: 33765873)
1. Motor "freezing" with oxaliplatin.
Patel MA; McDevitt RL; Sassack W; Zalupski MM
J Oncol Pharm Pract; 2021 Dec; 27(8):2014-2017. PubMed ID: 33765873
[TBL] [Abstract][Full Text] [Related]
2. Atypical presentation of acute neurotoxicity secondary to oxaliplatin.
Uña E
J Oncol Pharm Pract; 2010 Dec; 16(4):280-2. PubMed ID: 20015928
[TBL] [Abstract][Full Text] [Related]
3. Unusual stroke-like symptoms with oxaliplatin use.
Soliman A; Habibi S; Dasanu CA
J Oncol Pharm Pract; 2023 Oct; 29(7):1766-1769. PubMed ID: 37323007
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
[TBL] [Abstract][Full Text] [Related]
5. Successful desensitization to oxaliplatin.
Mis L; Fernando NH; Hurwitz HI; Morse MA
Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
[TBL] [Abstract][Full Text] [Related]
6. Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report).
Sawai K; Goi T; Koneri K; Katayama K; Yamaguchi A
World J Surg Oncol; 2013 Aug; 11(1):203. PubMed ID: 23957924
[TBL] [Abstract][Full Text] [Related]
7. Sudden hearing loss due to oxaliplatin use in a patient with colon cancer.
Güvenç MG; Dizdar D; Dizdar SK; Okutur SK; Demir G
J Chemother; 2016 Aug; 28(4):341-2. PubMed ID: 25872564
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-Related Ocular Toxicity.
Mesquida M; Sanchez-Dalmau B; Ortiz-Perez S; Pelegrín L; Molina-Fernandez JJ; Figueras-Roca M; Casaroli-Marano R; Adán A
Case Rep Oncol; 2010 Nov; 3(3):423-427. PubMed ID: 21151636
[TBL] [Abstract][Full Text] [Related]
9. Cold aggravates abnormal excitability of motor axons in oxaliplatin-treated patients.
Bennedsgaard K; Ventzel L; Grafe P; Tigerholm J; Themistocleous AC; Bennett DL; Tankisi H; Finnerup NB
Muscle Nerve; 2020 Jun; 61(6):796-800. PubMed ID: 32133655
[TBL] [Abstract][Full Text] [Related]
10. Delayed hypersensitivity to oxaliplatin in a nigerian patient with colorectal cancer-A case report.
Aliyu UM; Okwonna CO
J Oncol Pharm Pract; 2021 Jul; 27(5):1258-1260. PubMed ID: 33131450
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity reactions to oxaliplatin in two asian patients.
Ng CV
Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290
[TBL] [Abstract][Full Text] [Related]
12. An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report.
Takahashi M; Niwa K; Ishiyama S; Sugimoto K; Komiyama H; Yaginuma Y; Kojima Y; Goto M; Okuzawa A; Tomiki Y; Sakamoto K
J Med Case Rep; 2014 Jun; 8():234. PubMed ID: 24969166
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced acute thrombocytopenia: a case report and review of the literature.
Suzuki K; Oda H; Sugawara Y; Masuya M; Nakase K; Fujioka M; Imai H; Katayama N
Intern Med; 2013; 52(5):611-5. PubMed ID: 23448774
[TBL] [Abstract][Full Text] [Related]
14. Transient bilateral abducens neuropathy with post-tetanic facilitation and acute hypokalemia associated with oxaliplatin: a case report.
Tan MH; Chay WY; Ng JH; Teh BT; Chew L
J Med Case Rep; 2010 Feb; 4():36. PubMed ID: 20205880
[TBL] [Abstract][Full Text] [Related]
15. Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy.
Leonard GD; Wagner MR; Quinn MG; Grem JL
Anticancer Drugs; 2004 Aug; 15(7):733-5. PubMed ID: 15269607
[TBL] [Abstract][Full Text] [Related]
16. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
Shao YY; Hong RL
Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
[TBL] [Abstract][Full Text] [Related]
17. Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin.
Rosique-Robles D; Vicent Verge JM; Borrás-Blasco J; Giner-Marco V; Casterá E; Galan-Brotons A; Abad J
Int J Clin Pharmacol Ther; 2007 Nov; 45(11):606-10. PubMed ID: 18077926
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients.
Burz C; Berindan-Neagoe IB; Balacescu O; Tanaselia C; Ursu M; Gog A; Vlase L; Chintoanu M; Balacescu L; Leucuta SE; Irimie A; Cristea V
J Gastrointestin Liver Dis; 2009 Mar; 18(1):39-43. PubMed ID: 19337632
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic intracranial hypertension and oxaliplatin: a causal association?
Painhas T; Amorim M; Soares R; Duarte L; Salgado-Borges J
Cutan Ocul Toxicol; 2015; 34(3):237-41. PubMed ID: 25198406
[TBL] [Abstract][Full Text] [Related]
20. Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.
Durand JP; Brezault C; Goldwasser F
Anticancer Drugs; 2003 Jul; 14(6):423-5. PubMed ID: 12853883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
